HN2003000100A - Compuestos utiles en terapia - Google Patents
Compuestos utiles en terapiaInfo
- Publication number
- HN2003000100A HN2003000100A HN2003000100A HN2003000100A HN2003000100A HN 2003000100 A HN2003000100 A HN 2003000100A HN 2003000100 A HN2003000100 A HN 2003000100A HN 2003000100 A HN2003000100 A HN 2003000100A HN 2003000100 A HN2003000100 A HN 2003000100A
- Authority
- HN
- Honduras
- Prior art keywords
- therapy
- treatment
- useful compounds
- dysfunction
- useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A COMPUESTOS NOVEDOSOS UTILES EN TERAPIA.TAMBIEN SE REFIERE A COMPOSICIONES QUE CONTIENEN TALES DERIVADOS Y A SU USO. TIENEN UTILIDAD POTENCIAL EN EL TRATAMIENTO DE LA HIPERTENSION, EL INFARTO DE MIOCARDIO, DISFUNCION ERECTIL MASCULINA (MED), HIPERLIPIDEMIA, ARRITMIA CARDIACA, GLAUCOMA E HIPERPLASIA PROSTATICA BENIGNA (BPH). TAMBIEN PUEDE SER UTILES EN EL TRATAMIENTO DE LA DISFUNCION DE EXCITACION SEXUAL FEMENINA (FSAD).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0206033.3A GB0206033D0 (en) | 2002-03-14 | 2002-03-14 | Compounds useful in therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
HN2003000100A true HN2003000100A (es) | 2003-12-15 |
Family
ID=9932974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HN2003000100A HN2003000100A (es) | 2002-03-14 | 2003-03-13 | Compuestos utiles en terapia |
Country Status (19)
Country | Link |
---|---|
US (1) | US6936619B2 (es) |
EP (1) | EP1483257B1 (es) |
JP (1) | JP2005532275A (es) |
AR (1) | AR038949A1 (es) |
AT (1) | ATE339414T1 (es) |
AU (1) | AU2003209594A1 (es) |
BR (1) | BR0308407A (es) |
CA (1) | CA2479016A1 (es) |
DE (1) | DE60308332T2 (es) |
ES (1) | ES2271618T3 (es) |
GB (1) | GB0206033D0 (es) |
GT (1) | GT200300059A (es) |
HN (1) | HN2003000100A (es) |
MX (1) | MXPA04008939A (es) |
PA (1) | PA8569501A1 (es) |
PE (1) | PE20040265A1 (es) |
TW (1) | TW200305420A (es) |
UY (1) | UY27711A1 (es) |
WO (1) | WO2003076427A1 (es) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6900220B2 (en) * | 2001-01-02 | 2005-05-31 | Syntex (U.S.A.) Llc | Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists |
DE60307483T2 (de) | 2002-08-07 | 2007-07-05 | Novartis Ag | Organische verbindungen als mittel zur behandlung von aldosteronbedingten zuständen |
US20040132728A1 (en) * | 2002-09-17 | 2004-07-08 | Pfizer Inc | Combinations of atorvastatin and alpha1adrenergic receptor antagonists |
GB0221579D0 (en) * | 2002-09-17 | 2002-10-23 | Pfizer Ltd | Combinations of atorvastatin and, adrenergic receptor antagonists |
GB0225908D0 (en) * | 2002-11-06 | 2002-12-11 | Pfizer Ltd | Treatment of female sexual dysfunction |
BRPI0412163A (pt) * | 2003-07-02 | 2006-08-22 | Hoffmann La Roche | derivados de quinazolinona 5-substituìda |
TW200530235A (en) | 2003-12-24 | 2005-09-16 | Renovis Inc | Bicycloheteroarylamine compounds as ion channel ligands and uses thereof |
WO2005089804A2 (en) * | 2004-03-16 | 2005-09-29 | Pfizer Limited | Combinations of hmg-coa reductase inhibitors and alpha1 adrenergic receptor antagonists |
EP1595881A1 (en) * | 2004-05-12 | 2005-11-16 | Pfizer Limited | Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands |
US7793137B2 (en) | 2004-10-07 | 2010-09-07 | Cisco Technology, Inc. | Redundant power and data in a wired data telecommunincations network |
FR2870846B1 (fr) | 2004-05-25 | 2006-08-04 | Sanofi Synthelabo | Derives de tetrahydroisoquinolylsulfonamides, leur preparation et leur utilisation en therapeutique |
US7402596B2 (en) | 2005-03-24 | 2008-07-22 | Renovis, Inc. | Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
MX2007013595A (es) | 2005-05-04 | 2008-01-24 | Renovis Inc | Compuestos heterociclicos fusionados y composiciones y usos de estos. |
EP1790646A1 (fr) * | 2005-11-24 | 2007-05-30 | Sanofi-Aventis | Derives de Isoquinoline et Benzo[h]Isoquinoline, leur preparation et leur utilisation en thérapeutique en tant qu'antagonistes du recepteur de l'histamine H3. |
US8053440B2 (en) | 2007-02-01 | 2011-11-08 | Resverlogix Corporation | Compounds for the prevention and treatment of cardiovascular diseases |
US20080186971A1 (en) * | 2007-02-02 | 2008-08-07 | Tarari, Inc. | Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic |
WO2008123963A1 (en) | 2007-04-02 | 2008-10-16 | Renovis, Inc. | Pyrid-2-yl fused heterocyclic compounds, and compositions and uses thereof |
JP5498374B2 (ja) | 2007-04-17 | 2014-05-21 | エボテック・アーゲー | 2−シアノフェニル縮合複素環式化合物および組成物、ならびにその使用 |
US7928111B2 (en) * | 2007-06-08 | 2011-04-19 | Senomyx, Inc. | Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors |
US9603848B2 (en) | 2007-06-08 | 2017-03-28 | Senomyx, Inc. | Modulation of chemosensory receptors and ligands associated therewith |
US8859538B2 (en) * | 2007-06-21 | 2014-10-14 | Cara Therapeutics, Inc. | Uses of substituted imidazoheterocycles |
CN101686989B (zh) * | 2007-06-21 | 2016-10-19 | 卡拉治疗学股份有限公司 | 取代的咪唑并杂环 |
WO2009011904A1 (en) * | 2007-07-19 | 2009-01-22 | Renovis, Inc. | Compounds useful as faah modulators and uses thereof |
CN101417999A (zh) * | 2007-10-25 | 2009-04-29 | 上海恒瑞医药有限公司 | 哌嗪类衍生物,其制备方法及其在医药上的应用 |
US20100266504A1 (en) * | 2007-11-15 | 2010-10-21 | Takahiro Matsumoto | Condensed pyridine derivative and use thereof |
MY153622A (en) | 2008-07-31 | 2015-02-27 | Senomyx Inc | Processes and intermediates for making sweet taste enhancers |
JP5795304B2 (ja) | 2009-03-18 | 2015-10-14 | レスバーロジックス コーポレイション | 新規抗炎症剤 |
KR101892987B1 (ko) | 2009-04-22 | 2018-08-30 | 리스버로직스 코퍼레이션 | 신규한 소염제 |
EP2467382B1 (en) * | 2009-08-17 | 2014-06-25 | Merck Sharp & Dohme Corp. | Amino tetrahydro-pyridopyrimidine pde10 inhibitors |
ES2572908T3 (es) | 2011-10-14 | 2016-06-03 | Bristol-Myers Squibb Company | Compuestos de tetrahidroisoquinolina sustituidos como inhibidores del factor XIa |
AU2013299859B2 (en) | 2012-08-06 | 2017-06-15 | Firmenich Incorporated | Sweet flavor modifier |
CN104884427B (zh) * | 2012-10-15 | 2016-09-07 | 雷斯韦洛吉克斯公司 | 可用于合成苯甲酰胺化合物的化合物 |
JO3155B1 (ar) | 2013-02-19 | 2017-09-20 | Senomyx Inc | معدِّل نكهة حلوة |
CN105916858B (zh) | 2013-12-20 | 2018-09-14 | 埃斯特韦制药股份公司 | 稠合咪唑基衍生物、其制备和作为药物的用途 |
EP3149002B1 (en) * | 2014-05-28 | 2018-04-25 | F.Hoffmann-La Roche Ag | 5-oxa-2-azabicyclo[2.2.2]octan-4-yl and 5-oxa-2-azabicyclo[2.2.1]heptan-4-yl derivatives as taar1 modulators |
KR102662814B1 (ko) | 2015-03-13 | 2024-05-03 | 리스버로직스 코퍼레이션 | 보체 관련 질환을 치료하기 위한 조성물 및 치료 방법 |
CN105153048B (zh) * | 2015-07-31 | 2017-10-24 | 苏州大学 | 一种2,4‑喹唑啉二酮类化合物的制备方法 |
CN105237455A (zh) * | 2015-10-14 | 2016-01-13 | 湖南华腾制药有限公司 | 一种3-取代氮杂环丁烷的制备方法 |
SG11201804170RA (en) | 2015-12-17 | 2018-06-28 | Merck Patent Gmbh | Polycyclic tlr7/8 antagonists and use thereof in the treatment of immune disorders |
EP3409658B1 (en) * | 2016-01-29 | 2024-03-06 | ONO Pharmaceutical Co., Ltd. | Tetrahydronaphthalene derivative |
WO2018031434A1 (en) | 2016-08-08 | 2018-02-15 | Merck Patent Gmbh | Tlr7/8 antagonists and uses thereof |
BR112021002261A2 (pt) | 2018-08-07 | 2021-05-04 | Firmenich Incorporated | 2,2-dióxidos de 4-amino-1h-benzo[c][1,2,6]tiadiazina 5-substituídos e formulações e usos dos mesmos |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4085213A (en) * | 1976-01-28 | 1978-04-18 | Pfizer Inc. | Tetrazolo[A]quinazol-5-ones antiallergy and antiulcer agents |
NZ325248A (en) * | 1995-12-23 | 1999-09-29 | Pfizer Res & Dev | Quinoline and quinazoline compounds useful in therapy |
GB9700504D0 (en) * | 1997-01-11 | 1997-02-26 | Pfizer Ltd | Pharmaceutical compounds |
ATE295362T1 (de) * | 2001-01-02 | 2005-05-15 | Hoffmann La Roche | Chinazolone derivate als alfa 1a/b adrenozeptor antagonisten |
-
2002
- 2002-03-14 GB GBGB0206033.3A patent/GB0206033D0/en not_active Ceased
-
2003
- 2003-03-05 ES ES03743965T patent/ES2271618T3/es not_active Expired - Lifetime
- 2003-03-05 MX MXPA04008939A patent/MXPA04008939A/es unknown
- 2003-03-05 AT AT03743965T patent/ATE339414T1/de not_active IP Right Cessation
- 2003-03-05 BR BR0308407-8A patent/BR0308407A/pt not_active IP Right Cessation
- 2003-03-05 WO PCT/IB2003/000998 patent/WO2003076427A1/en active IP Right Grant
- 2003-03-05 DE DE60308332T patent/DE60308332T2/de not_active Expired - Fee Related
- 2003-03-05 AU AU2003209594A patent/AU2003209594A1/en not_active Abandoned
- 2003-03-05 JP JP2003574644A patent/JP2005532275A/ja not_active Withdrawn
- 2003-03-05 EP EP03743965A patent/EP1483257B1/en not_active Expired - Lifetime
- 2003-03-05 CA CA002479016A patent/CA2479016A1/en not_active Abandoned
- 2003-03-11 PE PE2003000247A patent/PE20040265A1/es not_active Application Discontinuation
- 2003-03-11 UY UY27711A patent/UY27711A1/es not_active Application Discontinuation
- 2003-03-12 AR ARP030100858A patent/AR038949A1/es unknown
- 2003-03-12 US US10/387,106 patent/US6936619B2/en not_active Expired - Fee Related
- 2003-03-13 TW TW092105474A patent/TW200305420A/zh unknown
- 2003-03-13 HN HN2003000100A patent/HN2003000100A/es unknown
- 2003-03-14 PA PA20038569501A patent/PA8569501A1/es unknown
- 2003-03-14 GT GT200300059A patent/GT200300059A/es unknown
Also Published As
Publication number | Publication date |
---|---|
AR038949A1 (es) | 2005-02-02 |
ES2271618T3 (es) | 2007-04-16 |
ATE339414T1 (de) | 2006-10-15 |
DE60308332T2 (de) | 2007-01-11 |
MXPA04008939A (es) | 2004-11-26 |
DE60308332D1 (de) | 2006-10-26 |
EP1483257A1 (en) | 2004-12-08 |
PA8569501A1 (es) | 2003-12-10 |
US6936619B2 (en) | 2005-08-30 |
AU2003209594A1 (en) | 2003-09-22 |
GB0206033D0 (en) | 2002-04-24 |
JP2005532275A (ja) | 2005-10-27 |
PE20040265A1 (es) | 2004-05-01 |
GT200300059A (es) | 2003-10-15 |
US20040029859A1 (en) | 2004-02-12 |
UY27711A1 (es) | 2003-10-31 |
EP1483257B1 (en) | 2006-09-13 |
CA2479016A1 (en) | 2003-09-18 |
BR0308407A (pt) | 2005-01-11 |
TW200305420A (en) | 2003-11-01 |
WO2003076427A1 (en) | 2003-09-18 |
WO2003076427A8 (en) | 2004-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HN2003000100A (es) | Compuestos utiles en terapia | |
CY1111386T1 (el) | Ενωσεις και μεθοδοι για αυξηση νευρογενεσης | |
CY1114448T1 (el) | Φαρμακευτικες συνθεσεις και χρηση αυτων στην αγωγη της γυναικειας σεξουαλικης δυσλειτουργιας | |
EA200300171A1 (ru) | Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения | |
RU2009120992A (ru) | Применение 3-андростандиола, необязательно в сочетании с агонистом 5-ht1а для лечения сексуальной дисфункции | |
ATE301652T1 (de) | Piperazinderivate als agonisten des melanocortin- rezeptors | |
DE60332433D1 (de) | Azolylaminoazine als proteinkinasehemmer | |
DE60332604D1 (de) | Azolylaminoazine als proteinkinasehemmer | |
CO5680108A1 (es) | Compuestos para el tratamiento de la disfuncion sexual femenina | |
ATE365733T1 (de) | Zusammensetzungen brauchbar als protein-kinase- inhibitoren | |
TNSN01130A1 (fr) | Formulations a liberation prolongee pour des secretagogues d'hormone de croissance | |
EA200200616A1 (ru) | Химические производные и их применение в качестве антителомеразного агента | |
TW200612919A (en) | Lonidamine analogues and their use in male contraception and cancer treatment | |
EP1689713A4 (en) | BENZYLETHER AND BETA-SECRETASE BENZYLAMINO INHIBITORS FOR TREATING ALZHEIMER'S DISEASE | |
PA8522801A1 (es) | Derivados de 4-fenil-piridin | |
DE60033649D1 (de) | Verbindungen und therapeutische methoden | |
EA201400423A1 (ru) | Фармацевтические препараты и их применение при лечении половой дисфункции у женщин | |
CO5550428A2 (es) | Metodos y materiales para el tratamiento de deficiencias de testosterona en varones | |
CL2007002392A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de hiperplasia prostatica benigna, enfermedad de barrett, asma, enfermedad de crohn, reparacion de musculo esqueletico y tendon, colitis ulcerosa y leishmaniasis. | |
UY27203A1 (es) | Bencimidazoles útiles en el tratamiento de la disfunción sexual | |
CL2003002293A1 (es) | Compuestos derivados de indazol; su composicion farmaceutica; su uso en el tratamiento de hipertension ocular. | |
CY1112638T1 (el) | Χρηση των παραγωγων ινδολιου ως ενεργοποιητες νurr-1 για την θεραπεια νοσου ραrκινsον | |
GT200400241A (es) | Prevencion y tratamiento de enfermedades cardiacas hipertensivas mediante el uso de los estrogenos selectivos8b-vinil-estra-1,3,5,(10)-trien-3,17b-diol y 17b-fluor-9a-vinil-estra-1,3,6,(10)-trien-3, 16a-diol | |
SE9904674D0 (sv) | Novel compounds | |
EA200501204A1 (ru) | Производные 3-(1-[3-(1,3-бензотиазол-6-ил)пропилкарбамоил]циклоалкил)пропановой кислоты в качестве ингибиторов нейтральной эндопептидазы (nep) |